Genetic diagnostic test of hepatocellular carcinoma by telomerase catalytic subunit mRNA

Oncology Reports

Volumn 5, Issue 6, 1998, Pages 1407-1412

  Wada, Emi ^a   Hisatomi, Hisashi ^a   Moritoyo, Takashi ^b   Kanamaru, Taichi ^c   Hikiji, Kazumasa ^a  

^a SRL INC   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c KOBE UNIVERSITY   (Japan)

Author keywords

Telomere, TRF, hTERT, HCC

Indexed keywords

MESSENGER RNA; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CORRELATION FUNCTION; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS; TELOMERE; TURNOVER TIME;

EID: 0031668294     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.6.1407     Document Type: Article

References (35)

1. Moyzis RK, Buckingham JM, Cram SH, et al: A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85: 6622-6626, 1988.
2. Yu GL, Bradley JD, Attardi LD, et al. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature 344: 126-132, 1990.
3. Hiyama K, Hiyama E, Ishioka S, et al: Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 87: 895-902, 1995.
4. Kojima H, Yokosuka O, Imazeki F, et al: Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology 112: 493-500, 1996.
5. Tahara H, Nakanishi T, Kitamoto M, et al: Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 55: 2734-2736, 1995.
6. Nouso K, Urabe Y, Higashi T, et al: Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Cancer 78: 232-236, 1996.
7. Nakashio R, Kitamoto M, Tahara H, et al: Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma. Int J Cancer 74: 141-147, 1997.
8. Ohta K, Kanamaru T, Morita Y, et al: Telomerase activity in hepatocellular carcinoma as a predictor of postoperative recurrence. J Gastroenterol 32: 791-796, 1997.
9. Hisatomi H, Kawaoto Y, Ohmura Y, et al: Detection of telomerase activity in hepatocellular carcinoma by fluorescence-based TRAP analysis. Int Hepatol Commun 6: 29-35, 1996.
10. Nakamura TM, Morin GB, Chapman KB, et al: Telomerase catalytic subunits homologs from fission yeast and human. Science 277: 955-999, 1997.
11. Nakayama J, Tahara H, Tahara E, et al: Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 18: 65-68, 1998.
12. Murakami Y, Hayashi K, Hirohashi S, et al: Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 51: 5520-5525, 1991.
13. Ueda H, Ullrich SJ, Gangemi JD, et al: Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 9: 41-47, 1995.
14. Emi M, Fujiwara Y, Nakajima T, et al: Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res 52: 5368-5372, 1992.
15. Zhang W, Hirohashi S, Tsuda H, et al: Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res 81: 108-111, 1990.
16. Buetow KH, Murray JC, Israel JL, et al: Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA 86: 8852-8856, 1989.
17. Miura N, Horikawa I, Nishimoto A, et al: Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet Cytogenet 93: 56-62, 1997.
18. Chang E and Harley CB: Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 92: 11190-11194, 1995.
19. Nouso K, Urabe Y, Higashi T, et al: Telomere length in human liver diseases. Liver 16: 293-297, 1996.
20. Aden DP, Fogel A, Plotkin S, et al: Controlled synthesis of HBsAg in a differentiated human liver carcinoma derived cell line. Nature 282: 615-616, 1979.
21. Chomczynski P and Sacchi N: Single-step of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
22. Kim NW, Piatyszek MA, Prowse KR, et al: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
23. Holt S, Norton JC, Wright WE, et al: Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Method Cell Sci 18: 237-248, 1996.
24. Brein TP, Kallakury BV, Lowry CV, et al: Telomerase activity in benign endometrium and endometrial carcinoma. Cancer Res 57: 2760-2764, 1997.
25. Mao L, El-Naggar AK, Fan YH, et al: Telomerase activity in head and neck squamous cell carcinoma and adjacent tissue. Cancer Res 56: 5600-5604, 1996.
26. Dalbagni G, Han W, Zhang ZF, et al: Evaluation of the telomeric repeat amplification (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Clin Cancer Res 3: 1593-1598, 1997.
27. Kubota Y, Nakada T, Sasagawa I, et al: Elevated levels of telomerase activity in malignant pheochromocytoma. Cancer 82: 713-717, 1998.
28. Hisatomi H, Nagao K and Komatsu H: Quantification of telomerase activity in human liver tissues by fluorescence-based TRAP analysis. Hepatol Res 7: 35-42, 1997.
29. Ogino M, Hisatomi H and Hanazono M: Antimmor effect of indomethasin and telomerase activity in the tumor in colon 26 bearing CDF1 mice. Proc Jpn Acad 73: 150-153, 1997.
30. Holt SE, Aisner DL, Shay JW, et al: Lack of cell cycle regulation of telomerase activity in human cells. Proc Natl Acad Sci USA 94: 10687-10692, 1997.
31. Ohashi K, Tsutsumi M, Kobitsu K, et al: Shortened telomere length in hepatocellular carcinomas and corresponding background liver tissues of patients infected with hepatitis virus. Jpn J Cancer Res 87: 419-422, 1996.
32. Vaziri H, Dragowska W, Allosopp RC, et al: Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 91: 9857-9860, 1994.
33. Suda T, Isokawa O, Aoyagi Y, et al: Quantitaten of telomerase activity in hepatocellular carcinoma: a possible aid for a prediction of recurrent diseases in the remnant liver. Hepatology 27: 403-406, 1998.
34. Kanamaru T, Morita Y, Ito T, et al: Surgical significance of telomerase activity in non-cancerous liver tissue from patients with hepatocellular carcinoma. Jpn J Cancer Res 89: 727-732, 1998.
35. Bryan TM, Englezou A, Gupta J, et al: Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240-4248, 1995.